Neurocrine Biosciences Inc (NASDAQ:NBIX)
| 98.23 Delayed Data As of Jun 24 |  +0.84 / +0.86%Today’s Change | 71.88 Today|||52-Week Range 108.02 | +15.33% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $9.4B |
Company Description
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The firm's product includes INGREZZA. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.
Contact Information
Neurocrine Biosciences, Inc. 12780 El Camino Real San Diego California 92130 |
Employees
Shareholders
| Individual stakeholders | 8.53% |
| Mutual fund holders | 58.96% |
| Other institutional | 37.16% |
Top Executives
| Kevin Charles Gorman | Chief Executive Officer & Director |
| Bill Wilson | Vice President-Information Technology & Operations |
| Matthew C. Abernethy | Chief Financial Officer |
| Dimitri E. Grigoriadis | Chief Research Officer |
| Eiry W. Roberts | Chief Medical Officer |
